Verona Pharma plc (VRNA) Tops Q4 EPS by 2c

Verona Pharma plc (NASDAQ: VRNA) reported Q4 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $35.65 million versus the consensus estimate of $6.14 million.

For earnings history and earnings-related data on Verona Pharma plc (VRNA) click here.

You May Also Be Interested In

• KeyBanc Downgrades Primoris Services Corporation (PRIM) to Sector Weight
• Western Union Co. (WU) Reiterated at Market Perform by Citizens amid Retail Decline
• Jefferies Starts FedEx Freight Holding Company (FDXF) at Buy